e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Experimental models and research in diffuse parenchymal lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2011 Abstract: Histological markers of epithelial-mesenchymal transition in idiopathic pulmonary fibrosis provide evidence of an alternative repair process
N. Lomas, N. Forsyth, M. Spiteri (Stoke-on-Trent, United Kingdom)
Source:
Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Session:
Experimental models and research in diffuse parenchymal lung diseases
Session type:
Thematic Poster Session
Number:
683
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Lomas, N. Forsyth, M. Spiteri (Stoke-on-Trent, United Kingdom). LSC 2011 Abstract: Histological markers of epithelial-mesenchymal transition in idiopathic pulmonary fibrosis provide evidence of an alternative repair process. Eur Respir J 2011; 38: Suppl. 55, 683
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Contribution of epithelial-to-mesenchymal transition to phenotypic changes in idiopathic interstitial pneumonias
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010
Late Breaking Abstract - Investigation of the epithelial-mesenchymal paracrine interactions in lung tissue repair and fibrosis.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Shared pathways of lung development and misled repair during pulmonary fibrosis
Source: International Congress 2015 – IPF: an airway-derived disease?
Year: 2015
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Proof of concept of a non-invasive screening tool to detect idiopathic pulmonary fibrosis (IPF) in an early stage
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Mechanism of bronchoalveolar duct junction (BADJ) remodeling in idiopathic pulmonary fibrosis (IPF) as base for new pathogenetic therapy
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour
Source: Eur Respir J 2007; 30: Suppl. 51, 488s
Year: 2007
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis?
Source: Breathe 2008; 4: 365
Year: 2008
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
The myofibroblast in pulmonary fibrosis displays distinct functional characteristics, depending on its source of origin
Source: International Congress 2014 – ILDs 3
Year: 2014
Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex staining approach
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept